Non-syndromic metopic craniosynostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3366OMIM:190440Q75.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic metopic craniosynostosis, also known as isolated metopic synostosis or trigonocephaly, is a congenital condition in which the metopic suture — the fibrous joint running along the midline of the forehead from the anterior fontanelle to the root of the nose — fuses prematurely before or shortly after birth. Normally, this suture remains open during infancy to allow brain growth and closes between 3 and 9 months of age. When it fuses too early, the skull cannot expand normally in the lateral (side-to-side) direction at the forehead, resulting in a characteristic triangular-shaped forehead (trigonocephaly), a prominent midline forehead ridge, hypotelorism (closely spaced eyes), and bitemporal narrowing. The term 'non-syndromic' indicates that this craniosynostosis occurs in isolation, without the additional anomalies seen in syndromic forms such as Crouzon or Apert syndrome. The condition primarily affects the skeletal system (skull bones) and can secondarily impact the brain if intracranial pressure becomes elevated due to restricted skull growth, though this is less common in single-suture synostosis. Clinical severity ranges from mild cosmetic deformity with a visible metopic ridge to more pronounced trigonocephaly with functional concerns. Some children may experience developmental delays, visual disturbances, or increased intracranial pressure, though many have normal neurological development. Treatment is primarily surgical. For significant trigonocephaly, open cranial vault remodeling surgery is typically performed between 6 and 12 months of age to reshape the forehead and orbital rims, allowing normal brain growth and improving cosmetic appearance. Endoscopic strip craniectomy with postoperative helmet therapy is an alternative minimally invasive approach when performed early, usually before 3 to 4 months of age. Mild cases with only a palpable metopic ridge and no significant skull deformity may be monitored without surgical intervention. Long-term outcomes after surgical correction are generally favorable, with most children achieving normal head shape and neurological development.

Also known as:

Clinical phenotype terms— hover any for plain English:

Metopic synostosisHP:0011330PapilledemaHP:0001085
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic metopic craniosynostosis.

View clinical trials →

No actively recruiting trials found for Non-syndromic metopic craniosynostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic metopic craniosynostosis community →

No specialists are currently listed for Non-syndromic metopic craniosynostosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic metopic craniosynostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic metopic craniosynostosisForum →

No community posts yet. Be the first to share your experience with Non-syndromic metopic craniosynostosis.

Start the conversation →

Latest news about Non-syndromic metopic craniosynostosis

No recent news articles for Non-syndromic metopic craniosynostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic metopic craniosynostosis

What is Non-syndromic metopic craniosynostosis?

Non-syndromic metopic craniosynostosis, also known as isolated metopic synostosis or trigonocephaly, is a congenital condition in which the metopic suture — the fibrous joint running along the midline of the forehead from the anterior fontanelle to the root of the nose — fuses prematurely before or shortly after birth. Normally, this suture remains open during infancy to allow brain growth and closes between 3 and 9 months of age. When it fuses too early, the skull cannot expand normally in the lateral (side-to-side) direction at the forehead, resulting in a characteristic triangular-shaped fo

How is Non-syndromic metopic craniosynostosis inherited?

Non-syndromic metopic craniosynostosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Non-syndromic metopic craniosynostosis typically begin?

Typical onset of Non-syndromic metopic craniosynostosis is neonatal. Age of onset can vary across affected individuals.